DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Nishino M, Gargano M, Suda M. et al.
Optimizing immune-related tumor response assessment: Does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?.
2014
DOI: 10.1186/2051-1426-2-17
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.